Anti-EGFR Recombinant Antibody (Nimotuzumab)

CAT#: TAB-710

Recombinant humanized (from mouse) antibody expressed in CHO binding to human EGFR. Nimotuzumab is a humanized monoclonal antibody that as of 2014 had orphan status in the US and EU for glioma, and marketing approval in India, China, and other countries for squamous cell carcinomas of the head and neck.

Published Data Tested Data Gene Expression
Figure 1 EGFR signal transduction and effects of EGFR inhibition on downstream targets. Figure 2 EGFR signal transduction and effects of EGFR inhibition on downstream targets.
Figure 1 Anti-EGFR Recombinant Antibody (TAB-710) in WB Figure 2 Anti-EGFR Recombinant Antibody (TAB-710) in ELISA
Figure 1 IF staining of human cell line A-431 Figure 2 IF staining of human cell line U-251 MG Figure 3 Colon Figure 4 Liver Figure 5 Kidney Figure 6 Testis Figure 7 Placenta Figure 8 Lymph node Figure 9 RNA cell line category: Cell line enriched (A-431)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG1 - kappa
  • Species Reactivity
  • Human
  • Applications
  • ELISA, IP, FC, FuncS, Neut, IF, IHC
  • Trade name
  • TheraCIM
  • CAS
  • 780758-10-3
  • Generic Name
  • nimotuzumab
  • Biological Half-Life
  • 62–304 hours
  • ATC Code
  • L01XC
  • MW
  • 147,659.45 g/mol
  • Related Disease
  • Glioma cancers

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at -20°C. Avoid multiple freeze/thaw cycles.

Applications

  • Application Notes
  • The EGFR antibody has been reported in applications of Activ, WB.

Target

  • Alternative Names
  • nimotuzumab;TheraCIM;780758-10-3;hR3;h-R3;TheraCIM;BIOMAb EGFR;TheraCIM;Theraloc;CIMAher;EGFR;epidermal growth factor receptor;epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) , ERBB;ERBB1;erythroblastic le
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-710. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Reliable and Sturdy
The antibody has a long shelf life and is stable for months. The lot I've been using for various experiments is still operating just as it did when it was initially used.
Breast cancer biomarkers at key points during disease progression
Easy to Use
This antibody comes with a detailed how-to instruction and is easy to use. Every sample I tested had assays run on it, and the outcomes are repeatable and highly consistent.
Breast cancer biomarkers at key points during disease progression
Affordable and Useful
This antibody is really inexpensive when you take into account its high quality and performance. It exceeded all of my expectations in a variety of research applications. Very strongly suggested!

Q&As

  1. Can this antibody detect low-abundance proteins?

    A: Yes, but it may require optimizing assay conditions, increasing sample volume, or using high-sensitivity detection methods to improve signal.

  2. How do I choose the right lysis buffer for my samples?

    A: The choice of lysis buffer depends on your target protein's localization and characteristics. For example, RIPA buffer is suitable for cytoplasmic and nuclear proteins.

  3. How do I know if the antibody reagent is contaminated?

    A: Signs of contamination include cloudiness, precipitates, or unusual results in your assays. It's crucial to use aseptic techniques and aliquot into sterile containers.

View the frequently asked questions answered by Creative Biolabs Support.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-710, RRID: AB_3111988)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Nimotuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Nimotuzumab.

Related Diseases

Related Signaling Pathways

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Nimotuzumab"

Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-710)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human EGFR. It is a humanized monoclonal antibody.
DrugMonitor™ Anti-Nimotuzumab Antibody (VS-1224-YC808)
Nimotuzumab (h-R3), a humanized monoclonal antibody targeting EGFR, has shown promising efficacy combined with radiation in several cancer types, meriting further investigation. The DrugMonitor™ Anti-Nimotuzumab Antibody (VS-1224-YC808) is an anti-drug antibody (ADA) against Nimotuzumab. This drug-based antibody is raised in mice immunized with the Nimotuzumab. The anti-Nimotuzumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Nimotuzumab in samples.

See other products for "EGFR"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOB-1078z Mouse Anti-EGFR Recombinant Antibody (clone 42C11) WB, ELISA, FC, IF, IHC, FuncS Mouse IgG1, κ
PABL-462 Human Anti-EGFR Recombinant Antibody (clone C225) FC Human IgG
PABL-463 Human Anti-EGFR Recombinant Antibody (PABL-463) ELISA, WB, FuncS Humanized IgG
TAB-477CQ Human Anti-EGFR Recombinant Antibody (clone Laprituximab) ELISA, IHC, FC, IP, IF, WB Chimeric (mouse/human) IgG1, κ
MOB-052LC Mouse Anti-EGFR Recombinant Antibody (clone 7H7) WB, IP Mouse IgG
CAT Product Name Application Type
TAB-0225CL Human Anti-EGFR Recombinant Antibody (TAB-0225CL) Block, Inhib, FuncS, Apop, In vivo Chimeric (Mouse/Human) IgG1
TAB-0225CL-F(E) Human Anti-EGFR Recombinant Antibody; Fab Fragment (TAB-0225CL-F(E)) Block, Inhib, FuncS, Apop, In vivo Chimeric (Mouse/Human) Fab
TAB-302MZ Human Anti-EGFR Recombinant Antibody (TAB-302MZ) ELISA Chimeric (mouse/human) IgG1
TAB-308MZ Human Anti-EGFR Recombinant Antibody (TAB-308MZ) FuncS Chimeric antibody (mouse/human)
TAB-464CQ Anti-Human EGFR Recombinant Antibody (TAB-464CQ) ELISA, IHC, FC, IP, IF, FuncS IgG1, κ
CAT Product Name Application Type
Gly-055LC-1 Recombinant Anti-Human EGFR Antibody (Fc glycosylation/High-mannose glycosylated) ELISA Chimeric antibody (mouse/human)
CAT Product Name Application Type
Gly-167LC Recombinant Anti-Human EGFR Antibody (Non-glycosylated) ELISA Human antibody
CAT Product Name Application Type
BRD-0183MZ Chicken Anti-EGFR Polyclonal IgY WB Chicken antibody
CAT Product Name Application Type
NEUT-722CQ Rabbit Anti-EGFR Recombinant Antibody (clone CBL1011) Neut Rabbit IgG
NEUT-723CQ Mouse Anti-EGFR Recombinant Antibody (clone CBL931) WB, IP, IHC, ICC, Neut Mouse IgG1
NEUT-724CQ Rabbit Anti-EGFR Recombinant Antibody (NEUT-724CQ) IF, FC, WB, IP, Neut Rabbit IgG
CAT Product Name Application Type
AFC-TAB-165 Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-165) Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody
AFC-TAB-464CQ Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-464CQ) ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody
AFC-TAB-003 Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-003) IF, IP, Neut, FuncS, ELISA, FC ADCC enhanced antibody
AFC-TAB-040 Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-040) ELISA, FC, IP, FuncS, IF, Neut ADCC enhanced antibody
AFC-TAB-119 Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-119) FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
CAT Product Name Application Type
VS-0424-XY84 AbPlus™ Anti-EGFR Magnetic Beads (pSEX81-6) IP, Protein Purification
CAT Product Name Application Type
VS-1024-XY177 Mouse Anti-NHP EGFR Recombinant Antibody (clone 225) IF, IP Mouse IgG1
CAT Product Name Application Type
VS-0125-FY28 Human Anti-EGFR (clone ABT-806) scFv-Fc Chimera FC, Cyt Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0225-XY102 CytoStream™ Mouse Anti-EGFR Recombinant Antibody (VS-0225-XY102) FC Mouse IgG1, kappa
CAT Product Name Application Type
VS-0425-YC340 Recombinant Anti-EGFR Vesicular Antibody, EV Displayed (VS-0425-YC340) ELISA, FC, Neut, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare